High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone

Daniel Heintel, Alberto Rocci, Heinz Ludwig*, Arnold Bolomsky, Simona Caltagirone, Martin Schreder, Sabine Pfeifer, Heinz Gisslinger, Niklas Zojer, Ulrich Jäger, Antonio Palumbo

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Journal article

110 Citations (Scopus)

Abstract

Cereblon (CRBN) has recently been identified as a target for immunomodulatory drugs (IMiDs) and its downregulation has been linked to resistance to lenalidomide. Here, we studied CRBN expression by real time polymerase chain reaction in 49 bone marrow samples of newly diagnosed patients with multiple myeloma treated with lenalidomide and dexamethasone. Median CRBN expression was 3.45 in patients who achieved complete response, and 3.75, 2.01, 0.78, and 0.70 in those with very good partial response, partial response, stable disease and progressive disease respectively. CRBN expression levels correlated significantly with response to lenalidomide treatment (r = 0.48; P < 0.001). Among established prognostic parameters, only beta-2-microglobulin correlated with cereblon (r = 0.66; P < 0.001). A close association of CRBN with interferon regulatory factor 4 (IRF4) (P < 0.001) and with CTNNB1 (P < 0.001) was found. Overall, a statistically significant association between baseline CRBN expression and response in MM patients treated with lenalidomide is shown. CRBN expression is closely associated with IRF4, which is an important target of IMiD therapy.

Original languageEnglish
Pages (from-to)695-700
Number of pages6
JournalBritish Journal of Haematology
Volume161
Issue number5
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone'. Together they form a unique fingerprint.

Cite this